With lots of devices in development -- including transseptal devices Sapien M3, HighLife Valve, Cephea, Intrepid, and ...

The new paper sums up the basics for clinicians who are starting to use 3D intracardiac echo, with an eye toward the future.

May 8, 2024 /PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announces the launch of CARTO ™ 3 System Version 8 ...

In this interview, Dr. Fu Wei, Director of Quality Management Department at BGI Genomics talks to AZoMedical about achieving and maintaining ISO/IEC 27001 and BS 10012 certifications. Isaac ...

Paid and presented by Biosense Webster. Atrial fibrillation (AFib) is fast becoming one of the world’s most significant health issues, affecting millions worldwide, but it is also one of the ...

Johnson & Johnson announced it has completed its acquisition of Shockwave Medical. Shockwave is now part of Johnson & Johns ...

"The breadth of data presented by Biosense Webster at this year's meeting underscores our commitment advancement of knowledge and innovation in the treatment of cardiac arrhythmias." The admIRE ...

"Johnson & Johnson acquires Shockwave in $13.1bn deal" was originally created and published by Medical Device Network, a ...

Secondary analysis of the pivotal ADVENT trial showed that PFA with the Farawave device was actually superior in one respect ...

Report Ocean published the latest research report on the Left Atrial Appendage (LAA) Closure Device Market. In order to comprehend a market holistically, a variety of factors must be evaluated, ...

Johnson & Johnson today announced it completed its $13.1 billion acquisition of Shockwave Medical and its intravascular ...